Physician Photo

Amir T. Fathi, MD

Assistant Professor of Medicine, Harvard Medical School

  • Phone: 617-724-1124
Departments
Hematology/Oncology
Department of Medicine

Specialties

  • Cancer Center
  • Leukemia
Clinical Interests
Acute myelogenous leukemia
Acute lymphocytic leukemia
Chronic myelogenous leukemia
Myeloproliferative diseases
Myelodysplastic syndrome (MDS)
Locations
Boston: Massachusetts General Hospital
Medical Education
MD, Yale University School of Medicine
Residency, Massachusetts General Hospital
Fellowship, Johns Hopkins Hospital
Board Certifications
Internal Medicine, American Board of Internal Medicine
Hematology, American Board of Internal Medicine
Medical Oncology, American Board of Internal Medicine
Gender
Male
Foreign Languages
Persian/Farsi
Patient Age Group
Adult
Accepting New Patients
Yes

Research

My research is focused on the development and clinical translation of novel therapies for acute leukemias.  I currently lead multiple clinical trials at the Dana Farber Harvard Cancer Center for patients with advanced leukemia and hematologic malignancies.  I have a specific interest in studying FLT3 inhibition, aurora kinase inhibition, and antibody-drug conjugates as novel therapies.

Publications

Fathi AT, Sadrzadeh H, Borger DR, Ballen KK, Amrein PC, Attar EC, Foster J, Burke M, Lopez H, Matulis CR, Edmonds KM, Iafrate AJ, Straley K, Yen K, Agresta S, Schenkein DP, Hill C, Emadi A, Neuberg DS, Stone RM, Chen YB. Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic response. Blood, 2012;120(23):4649-52.

Fathi AT, Le L, Hasserjian RP, Sadrzadeh H, Levis M, Chen YB. FLT3 inhibitor-induced neutrophilic dermatosis. Blood, 2013;122(2):239-42.

Brunner AM, Campigotto F, Sadrzadeh H, Drapkin BJ, Chen YB, Neuberg DS, Fathi AT. Trends in all-cause mortality among patients with CML: A SEER database analysis. Cancer, 2013;119(14):2620-9.

Fathi AT, Chabner BA. FLT3 inhibition as therapy: A record of trials and tribulations. Oncologist, 2011;16(8):1162-74.

Hematology/Oncology
Zero Emerson Place
Suite 118
Boston, MA 02114

Phone: 617-724-1124
Fax: 317-724-1126